HK1102427A1 - Compositions comprising strontium and vitamin d and uses thereof - Google Patents
Compositions comprising strontium and vitamin d and uses thereofInfo
- Publication number
- HK1102427A1 HK1102427A1 HK07110624.6A HK07110624A HK1102427A1 HK 1102427 A1 HK1102427 A1 HK 1102427A1 HK 07110624 A HK07110624 A HK 07110624A HK 1102427 A1 HK1102427 A1 HK 1102427A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- strontium
- vitamin
- compositions
- pharmaceutical composition
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Inorganic Chemistry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200400991 | 2004-06-25 | ||
DKPA200401733 | 2004-11-10 | ||
PCT/DK2005/000425 WO2006000224A2 (en) | 2004-06-25 | 2005-06-24 | Compositions comprising strontium and vitamin d and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1102427A1 true HK1102427A1 (en) | 2007-11-23 |
Family
ID=34972075
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK07110624.6A HK1102427A1 (en) | 2004-06-25 | 2007-10-02 | Compositions comprising strontium and vitamin d and uses thereof |
Country Status (16)
Country | Link |
---|---|
US (1) | US8658206B2 (xx) |
EP (1) | EP1768748B2 (xx) |
JP (2) | JP5070046B2 (xx) |
KR (1) | KR20070034075A (xx) |
AT (1) | ATE443541T1 (xx) |
AU (1) | AU2005256317B2 (xx) |
BR (1) | BRPI0512357A (xx) |
CA (1) | CA2571449C (xx) |
DE (1) | DE602005016803D1 (xx) |
DK (1) | DK1768748T4 (xx) |
EA (1) | EA011814B1 (xx) |
HK (1) | HK1102427A1 (xx) |
IL (1) | IL180144A0 (xx) |
MX (1) | MXPA06015187A (xx) |
NO (1) | NO20070206L (xx) |
WO (1) | WO2006000224A2 (xx) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080118603A1 (en) * | 2006-11-21 | 2008-05-22 | Lada Mark W | Nutritional beverage for optimal bone health |
WO2008061535A1 (en) * | 2006-11-21 | 2008-05-29 | Strontin Aps | Compositions comprising strontium and uses thereof in the treatment or prevention of gingivitis, periodontitis, periodontitis as a manifestation of systemic diseases, and necrotizing periodontal diseases. |
AU2008242867B2 (en) * | 2007-04-23 | 2014-01-23 | Baxter Healthcare S.A. | Fibrin compositions containing strontium compounds |
KR20100047869A (ko) * | 2007-07-19 | 2010-05-10 | 디에스엠 아이피 어셋츠 비.브이. | 친유성 헬스 성분의 정제화가능한 배합물 |
WO2009037583A2 (en) | 2007-08-03 | 2009-03-26 | Nucitec S.A. De C.V. | Compositions and methods for treatment and prevention of osteoarthritis |
EP2416756A2 (en) * | 2009-04-10 | 2012-02-15 | Mahmut Bilgic | Stable pharmaceutical compositions with high bioavailibility |
FR2945748A1 (fr) * | 2009-05-20 | 2010-11-26 | Debregeas Et Associes Pharma | Medicament a base de calcium et de vitamine d. |
FR2953139B1 (fr) * | 2009-11-27 | 2012-04-13 | Servier Lab | Composition pharmaceutique comprenant un sel de strontium, de la vitamine d et une cyclodextrine |
JP5827328B2 (ja) | 2010-07-07 | 2015-12-02 | アーデリクス,インコーポレーテッド | リン酸輸送を阻害する化合物及び方法 |
JP5827327B2 (ja) | 2010-07-07 | 2015-12-02 | アーデリクス,インコーポレーテッド | リン酸輸送を阻害する化合物及び方法 |
JP5827326B2 (ja) | 2010-07-07 | 2015-12-02 | アーデリクス,インコーポレーテッド | リン酸輸送を阻害する化合物及び方法 |
WO2012006475A1 (en) * | 2010-07-07 | 2012-01-12 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
WO2012054110A2 (en) | 2010-07-07 | 2012-04-26 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
CA2852591C (en) * | 2011-02-02 | 2019-02-12 | Ent Technologies Pty Ltd | Vitamin d3 compositions and uses thereof for the treatment of nasal passages |
EP2530068A1 (en) | 2011-05-31 | 2012-12-05 | Lacer, S.A. | New strontium salts, synthesis and use thereof in the treatment of osteoporosis |
WO2014044756A1 (en) * | 2012-09-20 | 2014-03-27 | Mokwalo SA | Strontium as anti microbial compound |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3345265A (en) * | 1963-10-09 | 1967-10-03 | Kendall & Co | Multiple layer tablet with calcium salt central core separated from soluble fluoride outer coating |
US3699221A (en) * | 1965-02-23 | 1972-10-17 | Murray L Schole | Dental preparations |
US3988434A (en) | 1972-08-07 | 1976-10-26 | Schole Murray L | Dental preparation |
FR2633619B1 (fr) | 1988-06-29 | 1991-02-08 | Adir | Nouveau sel de strontium, son procede de preparation et les compositions pharmaceutiques le renfermant |
FR2651497B1 (fr) | 1989-09-01 | 1991-10-25 | Adir | Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
FR2658816A1 (fr) * | 1990-02-27 | 1991-08-30 | Adir | Nouveaux sels de metaux alcalinoterreux d'oxa-polyacides leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
US5380530A (en) | 1992-12-29 | 1995-01-10 | Whitehill Oral Technologies | Oral care composition coated gum |
US5624906A (en) * | 1994-12-08 | 1997-04-29 | Lever Brothers Company, Division Of Conopco, Inc. | Oral hygiene compositions comprising heteroatom containing alkyl aldonamide compounds |
FR2749759B1 (fr) * | 1996-06-17 | 1999-11-26 | Adir | Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose |
CN1164603C (zh) | 2001-09-29 | 2004-09-01 | 南京化工大学 | 1,6-二磷酸果糖锶盐系列化合物及其制备方法和在医药中的应用 |
FR2844797B1 (fr) | 2002-09-24 | 2004-10-22 | Servier Lab | Nouveau procede de synthese industriel des tetraesters de l'acide 5-[bis (carboxymethyl)]-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates |
FR2844796A1 (fr) | 2002-09-24 | 2004-03-26 | Servier Lab | Nouveau procede de synthese industrielle du diester methylique de l'acide 5-amino-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates |
FR2844795B1 (fr) | 2002-09-24 | 2004-10-22 | Servier Lab | Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates |
CA2524610C (en) | 2003-05-07 | 2014-03-25 | Osteologix A/S | Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions |
PL1622629T3 (pl) * | 2003-05-07 | 2013-12-31 | Osteologix As | Kompozycja do kontrolowanego uwalniania zawierająca sól strontu |
DK1534305T3 (da) | 2003-05-07 | 2007-02-05 | Osteologix As | Behandling af brusk-/knoglelidelser med vandoplöselige strontiumsalte |
-
2005
- 2005-06-24 EP EP05750580.2A patent/EP1768748B2/en active Active
- 2005-06-24 WO PCT/DK2005/000425 patent/WO2006000224A2/en active Application Filing
- 2005-06-24 JP JP2007516973A patent/JP5070046B2/ja not_active Expired - Fee Related
- 2005-06-24 DE DE602005016803T patent/DE602005016803D1/de active Active
- 2005-06-24 BR BRPI0512357-7A patent/BRPI0512357A/pt not_active IP Right Cessation
- 2005-06-24 AU AU2005256317A patent/AU2005256317B2/en not_active Ceased
- 2005-06-24 EA EA200700130A patent/EA011814B1/ru active IP Right Revival
- 2005-06-24 AT AT05750580T patent/ATE443541T1/de not_active IP Right Cessation
- 2005-06-24 MX MXPA06015187A patent/MXPA06015187A/es not_active Application Discontinuation
- 2005-06-24 US US11/570,767 patent/US8658206B2/en not_active Expired - Fee Related
- 2005-06-24 KR KR1020077001916A patent/KR20070034075A/ko not_active Application Discontinuation
- 2005-06-24 DK DK05750580.2T patent/DK1768748T4/da active
- 2005-06-24 CA CA2571449A patent/CA2571449C/en not_active Expired - Fee Related
-
2006
- 2006-12-18 IL IL180144A patent/IL180144A0/en unknown
-
2007
- 2007-01-11 NO NO20070206A patent/NO20070206L/no not_active Application Discontinuation
- 2007-10-02 HK HK07110624.6A patent/HK1102427A1/xx not_active IP Right Cessation
-
2012
- 2012-07-13 JP JP2012157477A patent/JP2012193208A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EA200700130A1 (ru) | 2007-06-29 |
KR20070034075A (ko) | 2007-03-27 |
AU2005256317A1 (en) | 2006-01-05 |
JP2008503504A (ja) | 2008-02-07 |
JP2012193208A (ja) | 2012-10-11 |
JP5070046B2 (ja) | 2012-11-07 |
NO20070206L (no) | 2007-03-22 |
DK1768748T4 (da) | 2019-06-11 |
WO2006000224A2 (en) | 2006-01-05 |
DK1768748T3 (da) | 2010-02-01 |
US8658206B2 (en) | 2014-02-25 |
ATE443541T1 (de) | 2009-10-15 |
MXPA06015187A (es) | 2007-09-27 |
EP1768748B2 (en) | 2019-03-13 |
WO2006000224A3 (en) | 2006-05-18 |
EP1768748B1 (en) | 2009-09-23 |
DE602005016803D1 (de) | 2009-11-05 |
BRPI0512357A (pt) | 2008-03-04 |
EP1768748A2 (en) | 2007-04-04 |
IL180144A0 (en) | 2007-06-03 |
AU2005256317B2 (en) | 2011-09-15 |
EA011814B1 (ru) | 2009-06-30 |
CA2571449A1 (en) | 2006-01-05 |
CA2571449C (en) | 2015-12-08 |
US20080026037A1 (en) | 2008-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1102427A1 (en) | Compositions comprising strontium and vitamin d and uses thereof | |
TW200612892A (en) | Novel compounds | |
IN2012DN01233A (xx) | ||
TW200732296A (en) | Novel compounds | |
MY143795A (en) | Tetrahydropyridoindole derivatives | |
TW200621313A (en) | Pharmaceutical compositions | |
MY144992A (en) | Substituted 1,2,3,4-tetrahydroisoquinoline derivatives. | |
TW200621690A (en) | Novel compounds | |
SG146657A1 (en) | Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists | |
TW200716204A (en) | Pharmaceutical composition | |
TNSN07360A1 (en) | Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof | |
MX2007008790A (es) | Pirazolo piridinas sustituidas, composiciones que las contienen, metodo de produccion de las mismas, y su uso. | |
UA93709C2 (ru) | 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций | |
TW200745003A (en) | Novel compounds | |
ZA200806778B (en) | N-Hydroxyacrylamide compounds | |
TNSN08370A1 (en) | Tetrahydropyridothienopyrimidine compounds and methods of use thereof | |
UA103930C2 (ru) | Соединения и композиция для лечения паразитарных болезней | |
MX2009013501A (es) | Compuestos piperidinicos y sus usos. | |
UA89201C2 (ru) | Энантиомеры выбранных конденсированных пиримидонов и их применение для лечения и профилактики злокачественного новообразования | |
TW200501965A (en) | Highly pure fondaparinux sodium composition,process for preparing said composition and pharmaceutical compositions containing it as active principle | |
TW200509907A (en) | Indol-6-yl sulfonamide derivatives, their preparation and their use in medicaments | |
WO2005082413A3 (en) | Ciclesonide and glycopyrronium combination | |
SI1893237T1 (sl) | Farmacevtska zmes ki vsebuje organopolisiloksan elastomer in učinkovino v obliki raztopine | |
MX2008001608A (es) | Piperazinas acetilenicas como antagonistas de receptor de glutamato metabotropico. | |
TW200800993A (en) | Organic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20220626 |